As of January 22, 2025, BrainStorm Cell Therapeutics (BCLI) has a market cap of $12.063 million USD. According to our data, BrainStorm Cell Therapeutics is ranked No.8798 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $12.06 M |
-6.83%
|
Dec 31, 2024 | $12.95 M |
-43.95%
|
Dec 29, 2023 | $23.10 M |
-83.54%
|
Dec 30, 2022 | $0.14 B |
-59.00%
|
Dec 31, 2021 | $0.34 B |
-11.70%
|
Dec 31, 2020 | $0.39 B |
5.84%
|
Dec 31, 2019 | $0.37 B |
20.56%
|
Dec 31, 2018 | $0.30 B |
-9.44%
|
Dec 29, 2017 | $0.34 B |
54.33%
|
Dec 30, 2016 | $0.22 B |
-11.19%
|
Dec 31, 2015 | $0.24 B |
-39.92%
|
Dec 31, 2014 | $0.41 B |
76.30%
|
Dec 31, 2013 | $0.23 B |
-18.18%
|
Dec 31, 2012 | $0.28 B |
4.76%
|
Dec 30, 2011 | $0.27 B |
10.53%
|
Dec 31, 2010 | $0.24 B |
-26.92%
|
Dec 31, 2009 | $0.33 B |
333.33%
|
Dec 31, 2008 | $77.00 M |
-90.77%
|
Dec 31, 2007 | $0.83 B |
132.14%
|
Dec 29, 2006 | $0.36 B |
-37.78%
|
Dec 30, 2005 | $0.58 B |
-77.39%
|
Dec 31, 2004 | $2.55 B |
99.00%
|
Dec 31, 2003 | $1.28 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Mesoblast
MESO
|
$2.03 B |
0.000 M
|
Australia
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Vericel
VCEL
|
$2.89 B |
0.000 M
|
USA
|
Lineage Cell Therapeutics
LCTX
|
$0.15 B |
0.000 M
|
USA
|
Gamida Cell
GMDA
|
$4.34 M |
0.000 M
|
Israel
|
Market Cap | = | BCLI Stock Price | * | BCLI Shares Outstanding |
= | $2.12 | * | 5.70 M | |
= | $12.06 M |